Orchestra BioMed Holdings Ratios (2020-2026) | OBIO

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter)
95.15%85.04%95.18%95.19%96.22%94.10%90.21%82.06%94.52%94.34%93.11%77.08%94.93%94.50%94.31%99.84%70.91%
EBT Margin (Quarter)
-619.40%-1,967.83%-898.88%-921.03%-1,021.99%-1,853.33%-5,255.13%-4,656.49%-2,548.06%-3,237.53%-1,785.41%-6,362.85%-2,233.06%-2,579.90%-2,385.37%20.68%-22,504.55%
EBIT Margin (Quarter)
-592.15%-1,903.74%-865.61%-891.02%-991.84%-1,415.96%-3,466.35%-4,763.74%-2,326.29%-2,166.97%-1,655.72%-6,591.70%-2,179.84%-2,311.84%-2,359.23%21.85%-20,069.09%
EBITDA Margin (Quarter)
-592.15%-1,903.74%-865.61%-891.02%-991.84%-1,415.96%-3,466.35%-4,763.74%-2,326.29%-2,166.97%-1,655.72%-6,591.70%-2,179.84%-2,311.84%-2,359.23%21.85%-20,069.09%
Operating Margin (Quarter)
-592.15%-1,903.74%-865.61%-891.02%-991.84%-1,415.96%-3,466.35%-4,763.74%-2,326.29%-2,166.97%-1,655.72%-6,591.70%-2,179.84%-2,311.84%-2,359.23%21.85%-20,069.09%
Net Margin (Quarter)
-619.40%-1,967.83%-898.88%-921.03%-1,021.99%-1,853.33%-5,255.13%-4,656.49%-2,548.06%-3,237.53%-1,785.41%-6,362.85%-2,160.71%-2,579.90%-2,385.37%20.68%-18,778.18%
FCF Margin (Quarter)
-620.21%-2,052.62%-643.16%-797.64%-1,238.49%-1,149.40%-2,458.47%-4,187.40%-2,116.45%-1,325.58%-1,394.93%-5,392.89%-1,927.19%-1,861.36%-1,682.46%-7.62%-20,320.00%
Efficiency
Inventory Average (Quarter)
0.25M0.20M0.16M0.14M0.13M0.09M0.15M0.20M0.15M0.16M0.28M0.34M0.29M
Assets Average (Quarter)
162.07M161.96M161.85M161.68M161.55M115.12M82.11M115.93M131.08M121.12M105.78M88.92M77.51M73.85M75.75M67.61M50.94M73.82M109.83M107.76M
Invested Capital (Quarter)
9.60M
Asset Utilization Ratio (Quarter)
0.040.030.030.030.030.020.030.040.030.040.060.040.300.30
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-3.21-3.15-3.07-21.73-29.70-26.01-29.69-32.89-3.24-1.9444.42-10.49-2.02-12.7728.80-40.95-8.62-90.2818.71-8.24
Debt Ratio (Quarter)
0.100.070.080.080.190.240.340.140.120.14
Times Interest Earned (Quarter)
-3.21-3.15-3.07-21.73-29.70-26.01-29.69-32.89-3.24-1.9444.42-10.49-2.02-12.7728.80-40.95-8.62-90.2818.71-8.24
Valuation
Enterprise Value (Quarter)
-1.91M-1.78M-1.75M-1.42M-1.31M-0.74M-19.87M-127.13M-215.85M-108.49M-87.53M-23.35M-53.93M-95.87M-101.35M-49.88M-33.92M-95.82M-146.62M-84.63M
Return Ratios
Return on Sales (Quarter)
-0.06%-0.20%-0.09%-0.09%-0.10%-0.19%-0.53%-0.47%-0.25%-0.32%-0.18%-0.64%-0.22%-0.26%-0.24%0.00%-2.25%
Return on Capital Employed (Quarter)
-0.24%-3.35%-8.07%-20.16%-51.39%-37.62%-37.24%-49.03%-54.46%-69.28%-92.52%-104.29%-108.00%-131.99%-210.37%-141.53%-55.65%-58.43%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%